Literature DB >> 10768592

Contemporary approach to the classification of renal epithelial tumors.

V E Reuter1, J C Presti.   

Abstract

Our understanding of the morphologic and genetic features of renal epithelial neoplasia has brought about profound changes in the classification of these tumors. It is clear that they represent a heterogeneous group of tumors with distinct histopathologic, genetic, and clinical features ranging from benign to high-grade malignant. "Granular" and "sarcomatoid" carcinomas are not distinct entities, since tumors with granular or spindle cell features may be seen in many tumor-types. Using conventional pathologic tools such as hematoxylin and eosin staining, histochemistry, immunohistochemistry, and electron microscopy, we are able to properly classify the majority of these tumors. Nevertheless, approximately 6% to 7% of cases are impossible to classify in this fashion, thus requiring molecular genetic studies for proper characterization.

Entities:  

Mesh:

Year:  2000        PMID: 10768592

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  37 in total

Review 1.  Novel kinase inhibitors in renal cell carcinoma: progressive development of static agents.

Authors:  Apurva A Desai; Walter M Stadler
Journal:  Curr Oncol Rep       Date:  2005-03       Impact factor: 5.075

2.  Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.

Authors:  P Argani; C R Antonescu; P B Illei; M Y Lui; C F Timmons; R Newbury; V E Reuter; A J Garvin; A R Perez-Atayde; J A Fletcher; J B Beckwith; J A Bridge; M Ladanyi
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies.

Authors:  M H Voss; D A Bastos; C A Karlo; A Ajeti; A A Hakimi; D R Feldman; J J Hsieh; A M Molina; S Patil; R J Motzer
Journal:  Ann Oncol       Date:  2014-01-23       Impact factor: 32.976

4.  Initial clinical sensitivity and acquired resistance to MET inhibition in MET-mutated papillary renal cell carcinoma.

Authors:  Jennifer R Diamond; Ravi Salgia; Marileila Varella-Garcia; Rajani Kanteti; Patricia M LoRusso; Jeffrey W Clark; Ling-Guo Xu; Keith Wilner; S Gail Eckhardt; Keith A Ching; Maruja E Lira; Eric F P M Schoenmakers; James G Christensen; D Ross Camidge
Journal:  J Clin Oncol       Date:  2013-04-22       Impact factor: 44.544

5.  Evaluation of renal masses with contrast-enhanced ultrasound: initial experience.

Authors:  Scott Gerst; Lucy E Hann; Duan Li; Mithat Gonen; Satish Tickoo; Michael J Sohn; Paul Russo
Journal:  AJR Am J Roentgenol       Date:  2011-10       Impact factor: 3.959

6.  Inherited susceptibility to uterine leiomyomas and renal cell cancer.

Authors:  V Launonen; O Vierimaa; M Kiuru; J Isola; S Roth; E Pukkala; P Sistonen; R Herva; L A Aaltonen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

7.  Renal tumor with alpha B crystallin expression.

Authors:  Mee-Seon Kim; Hyoun Wook Lee; Eun Hee Lee
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

8.  The role of surgery in clinical management of patients with metastatic papillary renal cell carcinoma.

Authors:  Thomas Steiner; Hartmut Kirchner; Michael Siebels; Christian Doehn; Hans Heynemann; Zoltan Varga; Detlef Rohde; Joerg Schubert; Dieter Jocham; Christian Stief; Paolo Fornara; Rainer Hofmann; Stefan Loening; Jan Roigas
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-12       Impact factor: 4.553

9.  Metastatic type-2 papillary renal cell carcinoma responded to interleukin-2 therapy: case report.

Authors:  Takeo Kosaka; Shuji Mikami; Akira Miyajima; Mototsugu Oya
Journal:  Clin Exp Nephrol       Date:  2008-01-22       Impact factor: 2.801

10.  Arterial spin-labeling MR imaging of renal masses: correlation with histopathologic findings.

Authors:  Rotem S Lanzman; Phil M Robson; Maryellen R Sun; Amish D Patel; Kimiknu Mentore; Andrew A Wagner; Elizabeth M Genega; Neil M Rofsky; David C Alsop; Ivan Pedrosa
Journal:  Radiology       Date:  2012-10-09       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.